Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,223 public trials 1,013 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.

NCT03156114

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of Miami Miami, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
View all 15 locations
View Trial Details
Completed

A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations

NCT01897480

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Herlev and Gentofte Hospital Herlev, Capital Region, Denmark
  • Rigshospitalet Copenhagen, Denmark
  • Odense Universitetshospital Odense C, Syd, Denmark
  • CHU de Caen Hopital Cote de Nacre Caen, France
View all 45 locations
View Trial Details
Completed

A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants

NCT05136677

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +11 more
Locations
  • Local Institution - 0009 Beijing, Beijing Municipality, China
  • Local Institution - 0013 Harbin, Heilongjiang, China
  • Local Institution - 0006 Zhengzhou, Henan, China
  • Local Institution - 0005 Changsha, Hunan, China
View all 21 locations
View Trial Details
Completed

DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma

NCT04334759

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +13 more
Locations
  • University of California San Diego La Jolla, California, United States
  • University of Miami Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
View all 57 locations
View Trial Details
Completed

Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017

NCT03003468

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Illinois at Chicago Chicago, Illinois, United States
  • Indiana Univeristy Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • University of Iowa Hospital and Clinics Iowa City, Iowa, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details
Completed

Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)

NCT03285321

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Illinois Cancer Center Chicago, Illinois, United States
  • Indiana University Indianapolis, Indiana, United States
  • University of Louisville James Graham Brown Cancer Center Louisville, Kentucky, United States
View Trial Details

Related conditions